Dutch Ophthalmic Research Center

What Dutch Ophthalmic Research Center does

Dutch Ophthalmic Research Center (D.O.R.C. International) B.V. is a Netherlands-based medical device company founded in 1983 that designs, manufactures, and distributes surgical systems, instruments, and liquids for ophthalmic surgeons worldwide. The company's flagship platform is EVA NEXUS, an intelligent surgical system for both vitreoretinal and cataract surgery that incorporates proprietary VacuFlow VTi pump technology, SMART IOP active pressure compensation, and dual linear footswitch control, supported by a consumables ecosystem including TDC VELOCE high-speed cutters (up to 20,000 CPM), EVA AVETA trocar cannulas, EVA INICIO microinjection, NEXUS LED endo-illumination, and SURGICON ophthalmic micro knives. Its surgical-dye portfolio includes VisionBlue, the only FDA-approved trypan blue stain for anterior segment use with zero confirmed adverse events across 10 million+ cataract surgeries since 2004, and MEMBRANEBLUE-DUAL for combined ILM/ERM staining.

DORC operates a hybrid revenue model combining one-time capital equipment sales with recurring consumable pull-through, complemented by surgical liquids and reusable or disposable instruments. The company sells through wholly-owned sales and marketing subsidiaries in 15 countries (Austria, Belgium, Brazil, China, Finland, France, Germany, India, Italy, Netherlands, Norway, Spain, Sweden, UK, USA) and through an independent distributor network reaching 100+ countries. Primary customer segments are vitreoretinal surgeons, cataract surgeons, corneal surgeons (including DMEK), and the hospital ophthalmology departments that procure on their behalf. Pricing is not publicly disclosed and is negotiated through direct sales engagement or regional distributors.

In December 2023, Carl Zeiss Meditec AG announced its agreement to acquire DORC, completing the $1.07 billion transaction in April 2024. DORC now operates as a wholly-owned subsidiary of ZEISS Medical Technology, with product distribution increasingly routed through ZEISS channels in select markets. DORC continues to invest in product innovation, evidenced by the 2025 launch of TDC VELOCE and the March 2025 NMPA approval of ILM-Blue in China.

Name

Dutch Ophthalmic Research Center

Legal name

D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.

Website

https://dorcglobal.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

251–500 employees

Short description

Dutch Ophthalmic Research Center (DORC) designs and manufactures surgical systems, instruments, and surgical dyes for ophthalmic surgeons, anchored by its EVA NEXUS platform for vitreoretinal and cataract surgery. Founded in 1983 in the Netherlands, it sells in 100+ countries and is a wholly-owned subsidiary of Carl Zeiss Meditec AG following the April 2024 acquisition.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Equipment and Instruments

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)

akta.pro primary industry

Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades) (HLAHAJAJ)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Ophthalmic surgical equipment
• Vitreoretinal surgery instruments
• Cataract surgery devices
• Vitrectomy cutter systems
• Ophthalmic surgical dyes

Headquarters

HQ city

Zuidland

HQ country

Netherlands

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Ophthalmic Surgical Equipment and Consumables: DORC generates revenue through the sale of equipment, instruments, and liquids for ophthalmic surgery, including surgical systems (EVA NEXUS), consumables (vitrectomy cutters, trocars, laser probes), surgical instruments (microforceps, microscissors, backflush instruments), and surgical liquids (dyes, tamponades). Revenue is primarily one-time capital equipment sales combined with recurring consumable revenue.
2. Surgical Instruments (Reusable and Disposable): Sale of surgical instruments including microforceps, microscissors, membrane instruments, irrigation/aspiration handpieces, and ophthalmic knives (SURGICUT). Both reusable and single-use disposable variants available.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

DORC designs, manufactures, and sells ophthalmic surgical systems, instruments, and consumables used by ophthalmic surgeons for vitreoretinal and cataract procedures. Its flagship offering is the EVA NEXUS surgical platform paired with proprietary consumables including vitrectomy cutters, trocar cannulas, surgical dyes (VisionBlue, MEMBRANEBLUE-DUAL), and single-use ophthalmic knives (SURGICON), sold to hospitals and surgical centers worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• EVA NEXUS: Surgical system for ophthalmic surgery featuring VacuFlow VTi fluidics technology and SMART IOP functionality
• TDC VELOCE
• EVA AVETA
• EVA INICIO
• VisionBlue
• MEMBRANEBLUE-DUAL
• SURGICON
• ECO-line
• CERIOS

Products and services

• EVA NEXUS Surgical System Intelligent ophthalmic surgical platform featuring VacuFlow VTi pump technology and SMART IOP fluidics control for vitreoretinal and cataract surgery. Used by ophthalmic surgeons in hospital operating rooms.
• TDC VELOCE High-Speed Vitrectomy Cutter Next-generation two-dimensional vitrectomy cutter for the EVA NEXUS platform with cutting rates up to 20,000 CPM for efficient vitreous removal during retinal surgery. Used by vitreoretinal surgeons.
• EVA AVETA Trocar Cannula System Trocar cannula system with Push-Fit perfusion connector and laser-etched scleral retention feature for ophthalmic surgery; Hi-Flow design optimizes perfusion even in 27G. Used by vitreoretinal surgeons.
• VisionBlue Trypan Blue Stain FDA-approved trypan blue stain for capsulorhexis staining in cataract surgery. Trusted in over 10 million cataract surgeries since 2004 launch with zero confirmed adverse events. Used by cataract surgeons.
• MEMBRANEBLUE-DUAL Surgical Dye Dual-action surgical dye for ILM (Internal Limiting Membrane) and ERM (Epiretinal Membrane) staining during macular surgery. Used by vitreoretinal surgeons; trusted in over 3 million posterior procedures.
• SURGICON Ophthalmic Micro Knives Single-use ophthalmic surgical knives manufactured using proprietary chemical etching technology producing double-beveled cutting edges and smooth surfaces. Used by cataract and corneal surgeons.
• EVA INICIO Microinjection System First approved ophthalmic microinjection system developed for EVA NEXUS, offering precision and control for small-volume aqueous fluid injections at approximately 1 PSI with total surgeon control via footswitch.
• Vitreoretinal Surgical Instruments Portfolio of reusable and single-use vitreoretinal instruments including microforceps, microscissors, membrane instruments, and backflush instruments. Used by vitreoretinal surgeons for macular surgery, membrane peeling, and retinal detachment repair.
• Surgical Tamponades Ophthalmic surgical tamponades used in vitreoretinal surgery to support the retina post-operatively. Sold alongside surgical dyes as part of DORC's liquids portfolio to vitreoretinal surgeons.
• Phaco Handpiece and Tips Phacoemulsification handpieces and tips for cataract surgery used with the EVA NEXUS surgical platform, providing efficient ultrasound energy delivery for lens removal.

Quantifiable outcome

• VisionBlue has been used in over 10 million cataract surgeries since launch in 2004 with zero confirmed adverse events reported.
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Nine partnerships are on record, tiered minor.

• CIRCOminorStrategic or Co-development PartnerCIRCO is a Dutch government-supported initiative that encourages entrepreneurs and creative professionals to design or redesign products, services, and business models for circular economy integration. DORC participates in CIRCO to advance circular economy principles in ophthalmic surgical healthcare.
• ESCH-R (Expedition Sustainable Hospital)minorStrategic or Co-development PartnerESCH-R is a consortium of researchers from Dutch universities, surgeons, and industry partners studying the environmental impact of healthcare and accelerating the adoption of circular economy inventions in hospitals using the 10R framework.
• X!LEADminorStrategic or Co-development PartnerX!LEAD is a TU Delft-supported initiative connecting Master graduates with companies across industries to drive innovation. DORC collaborates with X!LEAD to foster innovation in its product development processes.
• The Elena Barraquer FoundationminorOthersDORC supports the Elena Barraquer Foundation, which provides eye care and surgical interventions for underserved populations.
• ACE GlobalminorOthersDORC is a Silver Partner of ACE Global, an organization focused on global eye care access and sustainability.
• The Eye Care FoundationminorOthersDORC supports the Eye Care Foundation, which works to prevent blindness and improve eye care access in developing countries.
• ESASO (European School for Advanced Studies in Ophthalmology)minorOthersDORC supports ESASO in its mission to provide advanced ophthalmology education and training for eye care professionals across Europe.
• Interreg 2 Seas 3DMed ProjectminorStrategic or Co-development PartnerDORC participates in the Interreg 2 Seas 3DMed project focused on the development and streamlined integration of 3D printing technologies to enable advanced medical treatment and its widespread application.
• SurgiconminorChannel Partner/ Reseller/ DistributorDORC acts as the distributor for Surgicon ophthalmic micro knives within the EU. Product availability is limited to selected EU countries and is subject to local regulatory approval.

Scale indicators6 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Alcon: Alcon is a global leader in ophthalmic surgical equipment, with direct overlap via the CONSTELLATION Vision System for vitreoretinal surgery, Centurion phacoemulsification platform, and NGENUITY 3D visualization — directly competing with DORC's EVA NEXUS in the same hospital OR channels.
• BVI Medical (Bausch + Lomb Vitreoretinal): BVI Medical (formerly Bausch + Lomb's vitreoretinal surgery business) competes directly in vitrectomy cutters, surgical instruments, and ophthalmic dyes, with product lines including the Stellaris PC and single-use instruments that overlap with DORC's portfolio.
• Johnson & Johnson Vision (Johnson & Johnson Surgical Vision): J&J Vision offers the TECNIS and VERITAS phaco platforms plus signature intraocular lenses, competing in the same ophthalmic surgical OR with hospitals that also evaluate DORC's EVA NEXUS and consumables.
• Geuder AG: German-based manufacturer of ophthalmic surgical instruments and equipment with strong vitreoretinal and cataract portfolios — a direct competitor to DORC in European markets, particularly in surgical instruments and consumables.
• NIDEK: Japanese ophthalmic equipment manufacturer offering surgical systems, phacoemulsification platforms, and ophthalmic instruments that compete with DORC's EVA NEXUS, particularly across Asian and emerging markets.

Broad incumbents

• Carl Zeiss Meditec AG: DORC's parent company and broader ophthalmic portfolio operator; while DORC is now a subsidiary, ZEISS as a whole competes in ophthalmic surgical microscopes, IOLs, and diagnostic equipment that are often sold to the same hospital customers as DORC's surgical systems.
• HOYA Corporation (HOYA Surgical Optics): HOYA is a major ophthalmic surgical player with IOLs and surgical products sold into the same hospital channels as DORC's products, creating competitive overlap on bundled surgical solutions even if HOYA is less directly focused on vitreoretinal equipment.

Emerging players

• Topcon Healthcare: Topcon has expanded into the ophthalmic surgical space (PASCAL and other laser/surgical products) with partial overlap to DORC's retinal surgery consumables and equipment, particularly in retinal laser probes and imaging-integrated surgical workflows.
• IRIDEX Corporation: IRIDEX specializes in retinal laser systems and probes used in vitreoretinal surgery, overlapping with DORC's laser probe consumables, though IRIDEX is a smaller, more focused player without DORC's full surgical platform.

Others

• STAAR Surgical: STAAR Surgical specializes in implantable collamer lenses (ICL/EVO) and is more of an adjacent player in ophthalmic surgical implants — overlapping with DORC primarily in shared ophthalmic surgical customer channels rather than direct product competition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@dorcglobal
• Facebookfacebook.com/DORC-Dutch-Ophthalmic-Research-Center-102690838041999
• LinkedInlinkedin.com/company/dutch-ophthalmic-research-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries9 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dutch Ophthalmic Research Center